Microvascular rarefaction, defined by the anatomical loss of microvessels, is a common characteristic of hypertension. Because the loss of vessels accompanies elevated blood pressure therapies aimed at reversing rarefaction represent candidate treatments for the disease. However, the development of such therapies requires an understanding of the functional relationship between network patterns and microvascular resistance over the time course of aging and the identification of the molecular players responsible for the impaired network growth. Recent data by the PI suggests that microvascular networks in the adult spontaneously hypertensive rat have increased arterial/venous anastomoses indicating that rarefaction is more complex that just a loss of vessels. We also have observed reduced perivascular cell expression of Neuron-Glia Antigen 2 (NG2), a chondroitin sulfate proteoglycan functionally involved in angiogenesis. NG2 is a positive regulator of endothelial cell proliferation and migration and directly influences the number of vessels present. Our observations suggest a novel molecular meachanism for microvascular rarefaction during hypertension. We hypothesize that reduced NG2 expression in hypertensive microvascular networks results in altered architectural patterns leading to elevated microvascular resistance. In order to test this hypothesis, we will complete the following specific aims using the spontaneously hypertensive rat model:
AIM 1 : Determine the microvascular network architecture and NG2 expression alterations over the time course of aging in spontaneously hypertensive rats.
AIM 2 : Establish that NG2 inhibition is sufficient to alter microvascular network architectures.
AIM 3 : Use a computational model to quantitatively determine the effect of altered hypertensive microvascular network architectures on microvascular network resistance. The results from this work will set new directions for investigating the relationships between microvascular structure and elevated microvasuclar resistance in hypertension.

Public Health Relevance

Elevated blood pressure in hypertension is associated with an age-related increase in microvascular resistance. Thus, design of hypertensive therapies aimed at reversing high blood pressure requires understanding how microvascular network architectures change over the time course of the disease, why microvascular network architectures change structure and the how network architectures influence resistance. The proposed work will serve to offer novel paradigms for investigating these questions.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tulane University
New Orleans
United States
Zip Code
Sweat, Richard S; Sloas, David C; Murfee, Walter L (2014) VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model. Microcirculation 21:532-40
Yoshida, Tadashi; Friehs, Ingeborg; Mummidi, Srinivas et al. (2014) Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-?-induced cardiomyocyte death. J Mol Cell Cardiol 75:141-51
Yoshida, Tadashi; Huq, Tashfin S; Delafontaine, Patrice (2014) Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration. J Biol Chem 289:26239-48
Kim, Sangkyu; Welsh, David A; Ravussin, Eric et al. (2014) An elevation of resting metabolic rate with declining health in nonagenarians may be associated with decreased muscle mass and function in women and men, respectively. J Gerontol A Biol Sci Med Sci 69:650-6
Lynch, Kristen M; Ahsan, Tabassum (2014) Correlating the effects of bone morphogenic protein to secreted soluble factors from fibroblasts and mesenchymal stem cells in regulating regenerative processes in vitro. Tissue Eng Part A 20:3122-9
Luo, Fayong; Zhuang, Yan; Sides, Mark D et al. (2014) Arsenic trioxide inhibits transforming growth factor-?1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Respir Res 15:51
Stapor, Peter C; Sweat, Richard S; Dashti, Derek C et al. (2014) Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res 51:163-74
Zsombok, Andrea (2013) Vanilloid receptors--do they have a role in whole body metabolism? Evidence from TRPV1. J Diabetes Complications 27:287-92
Jiang, Yanyan; Gao, Hong; Krantz, Amanda M et al. (2013) Reduced GABAergic inhibition of kidney-related PVN neurons in streptozotocin-treated type 1 diabetic mouse. J Neurophysiol 110:2192-202
Stapor, Peter C; Azimi, Mohammad S; Ahsan, Tabassum et al. (2013) An angiogenesis model for investigating multicellular interactions across intact microvascular networks. Am J Physiol Heart Circ Physiol 304:H235-45

Showing the most recent 10 out of 13 publications